The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
40 jobs Number of planned job losses
Announcement Date
30 November 2004
Employment effect (start)
1 January 2005
Foreseen end date
Description
Dutch pharmaceutical research company Pharma Bio Research (PBR) will cut 40 of its 315 full-time jobs in 2005. The job cuts will include forced redundancies. The company has reached an agreement with trade unions about a social plan. The company will close two of the six operating sites. Two research locations will remain active, one in Groningen and one in Zuidlaren. The research clinic in Assen will be closed.
Sources
1 December 2004: Dagblad van het Noorden
Citation
Eurofound (2004), Pharma Bio Research PBR, Internal restructuring in Netherlands, factsheet number 60821, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/60821.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
